Delivery Order SPE2DB20D2014-SPE2DB24FC66B

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 8 mg tablets in 30-count packages, with a total ceiling value of $14,406.77 and a period of performance through February 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,282,803 units of the prescription medication Ondansetron ODT 4 mg Tablet (30s). The contract has a ceiling value of $7,703.86 and is a firm fixed price delivery order with a period of performance through July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568183306 - Ondansetron ODT 8 mg Tablet 30s. The contract has a firm fixed price of $2,001.16 and a performance period ending on May 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of 4,565,446,703 units of Ondansetron ODT 4 MG Tablets (30s). The order is a firm fixed-price contract with a ceiling value of $7,999.00 and an ultimate completion date of August 15, 2024. Amerisourcebergen, a large pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $17,404.42 and an ultimate completion date of August 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for providing the pharmaceutical products to the government under this contract. This award is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,700.37, is for the supply of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565614740 Ondansetron ODT 4 mg tablets. The contract has a total ceiling value of $2,166.87 and an ultimate completion date of August 29, 2024. AmerisourceBergen was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order awarded to Amerisourcebergen Drug Corporation by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,513.89 firm-fixed-price contract is for the delivery of 4565911102 - Ondansetron ODT 8 mg tablets, with a completion date of September 24, 2024. This order is part of a larger Indefinite Delivery Contract valued up to $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical and medical supplies...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,116,842 units of the drug Ondansetron ODT 4 mg tablets. The award has a ceiling value of $5,097.98 and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.54 contract is for the delivery of Ondansetron ODT 8 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 and running through November 2026. This IDC allows the DLA to...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC66B
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565333214 - Ondansetron ODT 8 mg Tablet, 30s. The contract has a ceiling value of $13,197.18 and a period of performance through August 5, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' hospitals, and other government healthcare programs. This specific delivery order is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the comprehensive delivery of medical commodities to the Department of Defense.

Generated 11/1/24, 9:44 AM